McDonald Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Sell
27,300
-996
-4% -$139K 0.9% 35
2025
Q4
$3.47M Buy
28,296
+1,351
+5% +$164K 1.09% 24
2025
Q3
$2.99M Buy
26,945
+3,778
+16% +$429K 0.89% 28
2025
Q2
$2.57M Sell
23,167
-1,542
-6% -$164K 0.62% 41
2025
Q1
$2.77M Sell
24,709
-3,107
-11% -$321K 0.72% 38
2024
Q4
$2.57M Sell
27,816
-4,581
-14% -$412K 0.66% 40
2024
Q3
$2.72M Buy
32,397
+10,680
+49% +$815K 0.68% 40
2024
Q2
$1.49M Sell
21,717
-3,045
-12% -$203K 0.4% 71
2024
Q1
$1.81M Sell
24,762
-5,064
-17% -$389K 0.5% 58
2023
Q4
$2.42M Sell
29,826
-7,217
-19% -$562K 0.72% 40
2023
Q3
$2.78M Buy
37,043
+2,288
+7% +$176K 0.9% 31
2023
Q2
$2.68M Buy
34,755
+253
+0.7% +$20.2K 0.82% 34
2023
Q1
$2.86M Sell
34,502
-610
-2% -$50.5K 0.93% 29
2022
Q4
$3.01M Sell
35,112
-934
-3% -$74K 1.03% 24
2022
Q3
$2.22M Sell
36,046
-12,694
-26% -$800K 0.85% 31
2022
Q2
$3.01M Buy
48,740
+3,270
+7% +$202K 0.77% 32
2022
Q1
$2.7M Buy
45,470
+45,393
+58,952% +$2.9M 0.59% 46
2021
Q4
$5.59K Sell
77
-43,487
-100% -$3M 0.01% 235
2021
Q3
$3.04M Sell
43,564
-69
-0.2% -$4.85K 0.71% 37
2021
Q2
$3M Buy
43,633
+4,985
+13% +$333K 0.71% 38
2021
Q1
$2.5M Buy
38,648
+5,079
+15% +$328K 0.64% 43
2020
Q4
$1.96M Buy
+33,569
New +$2.03M 0.55% 53

Other funds holding GILD

McDonald Partners's GILD Position: Q1 2026 in Review

McDonald Partners reduced its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, selling an estimated $139K and leaving 27,300 shares worth $3.8M. The position accounts for 0.9% of the portfolio, ranked #35.

McDonald Partners first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • McDonald Partners held 27,300 shares of Gilead Sciences worth $3.8M as of Q1 2026.
  • McDonald Partners sold 996 Gilead Sciences shares in Q1 2026, an estimated $139K.
  • Gilead Sciences made up 0.9% of McDonald Partners's portfolio in Q1 2026, its #35 holding.
  • McDonald Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.